Solid Tumor and Hematologic Malignancies
1 clinical trials · Condition
◉ Watch Solid Tumor and Hematologic Malignancies
| Record | Firm | Date |
|---|---|---|
| MEK162 for Patients With RAS/RAF/MEK Activated Tumors (NCT01885195) | Pfizer | 2013-10-10 |
Track Solid Tumor and Hematologic Malignancies automatically
Every clearance here is in the API, with alerts when new ones post.